Fortem Financial Group, LLC Abb Vie Inc. Transaction History

Fortem Financial Group, LLC

$240 Million
Q3 2024

A detailed history of Fortem Financial Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fortem Financial Group, LLC holds 8,509 shares of ABBV stock, worth $1.53 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

8,509

Previous 8,509 -0.0%

Holding current value

$1.53 Million

Previous $1.68 Million -0.0%

% of portfolio

0.7%

Previous 0.7%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $223,150 - $271,487	1,362 Added 19.06%	8,509 $1.68 Million
Q2 2024 Aug 02, 2024	BUY	$154.79 - $180.76 $30,029 - $35,067	194 Added 2.79%	7,147 $1.23 Million
Q1 2024 May 01, 2024	BUY	$159.82 - $182.1 $172,285 - $196,303	1,078 Added 18.35%	6,953 $1.27 Million
Q4 2023 Jan 25, 2024	SELL	$137.6 - $154.97 $165,120 - $185,964	-1,200 Reduced 16.96%	5,875 $910,000
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $233,515 - $270,328	-1,748 Reduced 19.81%	7,075 $1.05 Million
Q2 2023 Jul 18, 2023	SELL	$132.51 - $164.9 $333,395 - $414,888	-2,516 Reduced 22.19%	8,823 $1.19 Million
Q1 2023 Apr 21, 2023	SELL	$144.61 - $166.54 $160,517 - $184,859	-1,110 Reduced 8.92%	11,339 $1.81 Million
Q4 2022 Jan 17, 2023	SELL	$138.31 - $165.87 $6,638 - $7,961	-48 Reduced 0.38%	12,449 $0
Q3 2022 Nov 01, 2022	BUY	$134.21 - $153.93 $87,907 - $100,824	655 Added 5.53%	12,497 $1.68 Million
Q2 2022 Jul 25, 2022	BUY	$137.62 - $174.96 $1.38 Million - $1.75 Million	9,994 Added 540.8%	11,842 $1.81 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $179,360 - $222,536	-1,359 Reduced 42.38%	1,848 $300,000
Q4 2021 Jan 20, 2022	SELL	$107.43 - $135.93 $2,685 - $3,398	-25 Reduced 0.77%	3,207 $434,000
Q3 2021 Oct 15, 2021	BUY	$106.4 - $120.78 $2,660 - $3,019	25 Added 0.78%	3,232 $349,000
Q2 2021 Jul 14, 2021	SELL	$105.21 - $117.21 $1.51 Million - $1.68 Million	-14,363 Reduced 81.75%	3,207 $361,000
Q1 2021 Apr 20, 2021	SELL	$102.3 - $112.62 $30,178 - $33,222	-295 Reduced 1.65%	17,570 $1.9 Million
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $73,165 - $98,781	909 Added 5.36%	17,865 $1.91 Million
Q3 2020 Oct 15, 2020	BUY	$85.91 - $100.83 $1.46 Million - $1.71 Million	16,956 New	16,956 $1.49 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortem Financial Group, LLC with notifications on news.

Account

Fortem Financial Group, LLC Abb Vie Inc. Transaction History